
Noumi sells to largest shareholder Arrovest at $0.1234/share, a 30% premium to the 30-day VWAP, to retire $610m in convertible notes due May 2027.
Noumi (ASX: NOU) will sell itself to its largest shareholder rather than face a $610 million convertible note repayment next year. The company entered a binding scheme implementation deed under which Arrovest will acquire all ordinary shares it does not already own.
Scheme shareholders receive $0.1234 cash per share, valuing Noumi's equity at about $34.2 million on a 100% basis. That is a 12.2% premium to the July 20 closing price and 30% above the 30-day volume-weighted average price.
The total transaction value is roughly $737 million when the equity and full note redemption are included. Current debt obligations stand at about $703 million, comprising the estimated redemption amount, net debt, and a limited-recourse facility.
Noumi's independent board committee unanimously recommended the share scheme and a separate option scheme. The recommendation is subject to no superior proposal emerging and an independent expert finding both arrangements in securityholders' best interests.
Chair Genevieve Gregor said the IBC viewed Arrovest's proposal as "the only credible and executable pathway identified that addresses the note maturity as part of a coordinated debt and equity solution and delivers a cash outcome to scheme shareholders and listed optionholders."
The company started a strategic review in August 2025. Over roughly a year, it tested a whole-company sale, individual business sales, recapitalisation, refinancing, and potential amendments or extensions to the note terms. None of those options could repay or refinance the notes in full on acceptable terms, or deliver comparable value to shareholders.
Arrovest separately agreed to buy 38.5% of the outstanding notes from institutional holders at a discount to their contracted redemption value. That lifts its holding to an expected 82%, potentially 83.5% if more noteholders accept an additional offer.
FY26 earnings snapshot
Noumi expects FY26 adjusted operating EBITDA of $61 million to $63 million, up from $57.4 million in FY25, based on preliminary unaudited accounts.
Plant-Based Milks posted record revenue of $186.3 million, up 2.4%. Segment adjusted EBITDA is expected to fall to $42 million to $44 million from $50.3 million. Higher sales and marketing investment and unrecovered input and distribution costs drove the decline.
Dairy & Nutritionals revenue rose 11.6% to $462 million. Export long-life milk sales returned to growth and commodity prices strengthened, supporting expected adjusted EBITDA of $21 million to $23 million compared with $11.1 million in FY25.
Milklab sales across both segments rose 5.5% for FY26. Milklab Plant-based retail sales climbed 44.6%. Milklab Oat grew 20.3%. A new Milklab Soy formulation launched during the second half.
PBM export sales increased 9.8%. Stronger retail demand and an 18.4% second-half rise in contract manufacturing offset contraction in the hotel, restaurant, and café channel. Milklab Plant total Australia revenue finished 3.4% higher.
Second-half pressure
The second-half sales mix shifted toward lower-margin contract manufacturing as Australia's Own Plant sales declined after retail ranging changes. Adjusted operating EBITDA ended about $5 million below the corresponding FY25 period.
Direct and indirect cost increases tied to the Middle East conflict cut second-half operating EBITDA by about $2 million across both segments. Noumi could not fully recover those increases through pricing across all channels and geographies.
Long-life dairy export sales climbed 49.4%. Bulk cream revenue rose 33.5%, or $14.3 million. Nutritional Ingredients sales increased 22.5%.
Noumi does not provide earnings guidance. The company said it "enters FY27 with a balanced range of opportunities and initiatives positioned to meet macro-economic challenges." It expects continued near-term volatility in global and domestic conditions. Key factors include dairy commodity prices, export demand, input costs, and broader changes in the Australian economy.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.